Co-administration of biocompatible self-assembled polylactic acid–hyaluronic acid block copolymer nanoparticles with tumor-penetrating peptide-iRGD for metastatic breast cancer therapy
Authors:
- 20 April 2018
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 6 (19) , 3163-3180
Abstract
The safe and efficient targeted delivery of chemotherapeutic drugs has remained a challenge in metastatic breast cancer therapy. Herein, we report a rational drug delivery strategy of co-administering tumor-penetrating peptide-iRGD with self-assembled amphiphilic block copolymer nanoparticles (HA–PLA) to inhibit tumor growth and lung metastasis in 4T1 breast cancer xenograft bearing mice through increasing drug accumulation in the tumors, inducing receptor-mediated tumor cell targeting without causing severe side effects. In vitro, HA–PLA displayed sustained and pH-sensitive release behavior. The cellular uptake of HA–PLA on high CD44-expressing 4T1 cells was significantly higher than the endocytosis on low CD44-expressing L929 fibroblast cells. In vivo, HA–PLA significantly extended the blood circulation time of DOX, displayed no “accelerated blood clearance (ABC) phenomenon” after repeated injection and decreased the side effects of DOX. When combined with iRGD, the drug distribution and penetration of HA–PLA in tumors were remarkably increased, resulting in better antitumor efficacy and the longest whole survival. In particular, the co-administration of iRGD with HA–PLA greatly increased drug distribution in the lung, which contributed to the effective inhibition of the lung metastasis of breast cancer. Therefore, co-administering iRGD with HA–PLA is a promising approach for metastatic breast cancer therapy.Keywords
Funding Information
- National Natural Science Foundation of China (81603045)
- Education Department of Sichuan Province (17ZA0117)
This publication has 65 references indexed in Scilit:
- Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxelBiomaterials, 2011
- Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer DrugsScience, 2010
- Biomimetic Doxorubicin Loaded Polymersomes from Hyaluronan-block-Poly(γ-benzyl glutamate) CopolymersBiomacromolecules, 2009
- Factors Affecting the Clearance and Biodistribution of Polymeric NanoparticlesMolecular Pharmaceutics, 2008
- Nanocarriers as an emerging platform for cancer therapyNature Nanotechnology, 2007
- Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug deliveryBiomaterials, 2007
- Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the WorldJournal of Clinical Oncology, 2006
- Liposome-encapsulated vincristine, vinblastine and vinorelbine: A comparative study of drug loading and retentionJournal of Controlled Release, 2005
- Doxorubicin in advanced breast cancer: Influence of schedule on response, survival and quality of lifeEuropean Journal of Cancer, 1992
- The endocytic hyaluronan receptor in rat liver sinusoidal endothelial cells is Ca+2‐independent and distinct from a Ca+2‐dependent hyaluronan binding activityJournal of Cellular Biochemistry, 1992